397
Participants
Start Date
December 28, 2017
Primary Completion Date
November 16, 2023
Study Completion Date
November 16, 2023
POMALYST® (Pomalidomide)
The recommended starting dose of POMALYST is 4 mg once daily taken orally on Days 1 to 21 of repeated 28-day cycles. The recommended dose of dexamethasone is 40 mg orally once daily on Days 1, 8, 15 and 22 of each 28-day treatment cycle
Hallym University Sacred Heart Hospital, Anyang
Soonchunhyang University Hospital, Bucheon-si
Korea University Ansan Hospital, Ansan
Ajou Unversity Medical Center, Suwon
Inha University Hospital, Incheon
Wonju Severance Christian Hospital, Wŏnju
Chungnam National University Hospital, Daejeon
Keimyung University Dongsan Medical, Daegu
Yeungnam University Medical Center, Daegu
Daegu Catholic University Medical Center, Daegu
Local Institution - 021, Daegu
Ulsan University Hospital, Ulsan
Inje University Busan Paik Hospital, Busan
Inje University Haeundae Paik Hospital, Busan
Dong-A University Hospital, Busan
Pusan National University Hospital, Busan
Kosin University Gospel Hospital, Busan
Pusan National University Yangsan, Yangsan
Gyeongsang National University Hospital, Jinju
Chonbuk National University Hospital, Jeonju
Chonnam National University Hwasun Hospital, Hwasun
Local Institution - 024, Jinju
Inje University Sanggye Paik Hospital, Seoul
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Samsung Medical Center, Seoul
The catholic University of Korea Seoul St. Maty's, Seoul
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul
Ewha Womans University Medical, Seoul
Korea University Guro Hospital, Seoul
Local Institution - 001, Seoul
Local Institution - 002, Seoul
Lead Sponsor
Celgene
INDUSTRY